Glycosyltransferase (GT) enzymes promote the formation
of glycosidic
bonds between a sugar molecule and a diversity of substrates. Heptosyltransferase
II (HepII) is a GT involved in the lipopolysaccharide (LPS) biosynthetic
pathway that transfers the seven-carbon sugar (l-glycero-d-manno-heptose, Hep)
onto a lipid-anchored glycopolymer (heptosylated Kdo2-Lipid
A, Hep-Kdo2-Lipid A, or HLA). LPS plays a key role in Gram-negative
bacterial sepsis, biofilm formation, and host colonization, and as
such, LPS biosynthetic enzymes are targets for novel antimicrobial
therapeutics. Three heptosyltransferases are involved in the inner-core
LPS biosynthesis, with Escherichia coli HepII being the last to be quantitatively characterized in vivo.
HepII shares modest sequence similarity with heptosyltransferase I
(HepI) while maintaining a high degree of structural homology. Here,
we report the first kinetic and biophysical characterization of HepII
and demonstrate the properties of HepII that are shared with HepI,
including sugar donor promiscuity and sugar acceptor-induced secondary
structural changes, which results in significant thermal stabilization.
HepII also has an increased catalytic efficiency and a significantly
tighter binding affinity for both of its substrates compared to HepI.
A structural model of the HepII ternary complex, refined by molecular
dynamics simulations, was developed to probe the potentially important
substrate–protein contacts. Ligand binding-induced changes
in Trp fluorescence in HepII enabled the determination of substrate
dissociation constants. Combined, these efforts meaningfully enhance
our understanding of the heptosyltransferase family of enzymes and
will aid in future efforts to design novel, potent, and specific inhibitors
for this family of enzymes.